Literature DB >> 6274254

A family affected with intestinal polyposis and gliomas.

D W Todd, L A Christoferson, R W Leech, L Rudolf.   

Abstract

The third affected family with Turcot syndrome is presented and the problems associated with the occurrence of familial aggregates of cancer are discussed. Turcot syndrome represents the unique and discrete occurrence of polyposis coli with glioblastoma multiforme, medulloblastoma, or both.

Entities:  

Mesh：

Year:  1981        PMID： 6274254     DOI： 10.1002/ana.410100413

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


  6 in total

1.  Turcot syndrome: a case report in an unsuspected setting.

Authors:  Hyuk Jun Chung; Seong Taek Oh; Jun Gi Kim; Won-Kyung Kang
Journal:  J Gastrointest Surg       Date:  2011-09-30       Impact factor: 3.452

2.  An unusual case of Turcot's syndrome associated with ileal adenocarcinoma, intestinal non-Hodgkin's lymphoma, and duodenal adenocarcinoma. Review of the classification and genetic basis of Turcot's syndrome.

Authors:  H R Murphy; W Taylor; A Ellis; R Sturgess
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

3.  Supratentorial astrocytic tumours of childhood: a clinicopathologic study of 41 cases.

Authors:  S Nishio; I Takeshita; K Fujii; M Fukui
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

Review 4.  Turcot's syndrome and familial adenomatous polyposis associated with brain tumor: review of related literature.

Authors:  H Itoh; K Hirata; K Ohsato
Journal:  Int J Colorectal Dis       Date:  1993-07       Impact factor: 2.571

5.  Turcot's syndrome: case report and review of the classification.

Authors:  L Cervoni; P Celli; R Tarantino; A Fortuna
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

6.  Incidence of second primary tumours among childhood cancer survivors.

Authors:  M M Hawkins; G J Draper; J E Kingston
Journal:  Br J Cancer       Date:  1987-09       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.